Last edition
News about "Duchenne Gene Therapy"
Duchenne gene therapy trials resumed
Pfizer is set to resume its late-stage clinical trials of a treatment for Duchenne muscular dystrophy after stopping in December because of a clinical hold.
Duchenne Gene Therapy | 02/05/2022 | By Sudeep Soparkar | 812
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members